CTNNB1 and neoplasm: There were significant reducations in the tumor burden across a wide dose range of the LNP-CTNNB1 (3, 1, 0.3, and 0.1 mg/kg), as evident grossly, by liver weight, and by LW/BW (Supplementary Fig. 2b–d, Fig. 1c–f).